Cart
sales@molnova.com
CHET3
CAS No. 2489231-47-0
CHET3( —— )
Catalog No. M36427 CAS No. 2489231-47-0
CHET3 is a highly selective allosteric activator for TASK-3-containing K2P channels. CHET3 has shown potent in vivo analgesic effects in various acute and chronic pain models in rodents.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 296 | In Stock |
|
| 10MG | 429 | In Stock |
|
| 25MG | 661 | In Stock |
|
| 50MG | 876 | In Stock |
|
| 100MG | 1181 | In Stock |
|
| 200MG | 1572 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCHET3
-
NoteResearch use only, not for human use.
-
Brief DescriptionCHET3 is a highly selective allosteric activator for TASK-3-containing K2P channels. CHET3 has shown potent in vivo analgesic effects in various acute and chronic pain models in rodents.
-
DescriptionCHET3 is a highly selective allosteric activator for TASK-3-containing K2P channels. CHET3 has shown potent in vivo analgesic effects in various acute and chronic pain models in rodents.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2489231-47-0
-
Formula Weight423.49
-
Molecular FormulaC21H21N5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(NC=1NC(CSC2=CC=C(C)C=C2)=CC(=O)N1)=N)C=3C=C4C(=CC3)OCCO4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-04895162
PF-04895162 (ICA-105665, PF 4895162) is an orally available agonist of neuronal Kv7 potassium channel, opens Kv7.2/7.3 and Kv7.3/7.5 potassium channels.
-
ML418
ML418 is a potent, selective and CNS penetrating Kir7.1 potassium channel blocker (IC50 = 310 nM), and also potently inhibits Kir6.2/SUR1.
-
Flupirtine maleate
A selective neuronal potassium channel (KCNQ/KV7 channel) activator that also has indirect NMDA receptor antagonist and GABAA receptor modulatory properties.
